Find out more about the members of TAC B by reading their biographies.
Dr Amanda Adler MD, PhD, FRCP
Consultant Physician, Addenbrooke's Hospital
Amanda Adler trained in economics, medicine and epidemiology and is a consultant physician with an interest in diabetes at Addenbrooke's Hospital, Cambridge. Other roles include honorary clinical epidemiologist in the MRC Epidemiology Unit, Institute of Metabolic Sciences, Cambridge and research associate, Diabetes Trials Unit, Oxford. Previous roles include Clinical Epidemiologist, UK Prospective Diabetes Study, advisor, UK National Screening Committee, and physician, University of Washington, Seattle. She chaired the NICE committee addressing Newer Agents for Blood Glucose Control in Type 2 Diabetes.
Dr Sanjeev Patel BM DM FRCP
Consultant Physician and Senior Lecturer in Rheumatology
Sanjeev's clinical duties include acute intaking medicine and rheumatology services with a special interest in bone diseases. He is Chair of the Medicines Management Committee of the Trust and Chair of the Rheumatology Speciality Advisory Committee to the Royal College of Physicians. His current research interests include the role of vitamin D in chronic diseases, and studies of secondary causes of osteoporosis and fractures, such as anorexia nervosa and chronic kidney disease.
Dr Carlo Berti
Consultant Psychiatrist and Hon. Lecturer, Kent and Medway Partnership Trust
Professor John Cairns
Professor of Health Economics Public Health and Policy, London School of Hygiene and Tropical Medicine
John Cairns is a graduate in Economics of the Universities of Aberdeen and York. He is currently Professor of Health Economics in the department of Public Health and Policy, at the London School of Hygiene and Tropical Medicine. He is a member of the Health Technology Assessment Commissioning Board, the Scottish Medicines Consortium and Advisory Committee on the Safety of Blood, Tissues and Organs.
Mr Mark Chapman
Director, Health Economics & Commissioning Medtronic UK & Ireland
Mark has been with Medtronic since 2001. He currently heads the health economics team where he is responsible for Medtronic’s strategies as related to health economics, economic regulator submissions and associated clinical study design as related to the quantification of cost and effectiveness. Prior to joining Medtronic, he trained as a Clinical Physiologist, and worked for 11 years within the NHS tertiary cardiac care, with a specialist interest in complex cardiac devices.
Mark is a past member of the external advisory board and the University of Leeds EPSRC Centre for Innovative Manufacturing of Medical Devices. He has undertaken secondments within the UK Government, Office for Life Science, Department of Business, as Med Tech Policy Advisor, supporting the work of the UK Life Sciences Strategy.
Mark holds a BSc (hons) in Applied Biological Sciences and a Post Graduate Diploma in Health Economics. He received his MBA from Keele University, School of Public Policy.
Mr Diar Fattah
Head of Medicines Optimisation, NHS Dartford, Gravesham and Swanley CCG
Diar is the Associate Director of Medicines Optimisation at Dartford, Gravesham and Swanley CCG. Diar takes the lead on the provision of medicines optimisation on all matters relating to medicines use, prescribing and the provision of pharmaceutical services to the CCG. His work has been focused on combatting inappropriate polypharmacy with the use of healthcare data analytics.
Previously, he has worked as Medicine Optimisation Pharmacist at Medway CCG, a tutor at the Centre for Pharmacy Postgraduate Education (CPPE) based at the University of Manchester and a pharmacist clinical advisor in NHS 111.
Diar holds a masters in Pharmacy and is currently working towards his masters in Health Economics and Policy.
Ms Susan Faulds
Lecturer, University of Southampton
Susan is a Principle Teaching Fellow and Director of Postgraduate Taught programmes in the Faculty of Health Sciences at the University of Southampton. As a registered nurse, Susan’s background is critical care medicine and her teaching and research reflects this.
Dr Mark Glover
MRC Clinician Scientist, Associate Professor and Honorary Consultant Physician, University of Nottingham
Mark trained in pre-clinical pharmacology and clinical medicine at Gonville and Caius College, Cambridge. He is a Clinical Pharmacologist and General Physician at the University of Nottingham and Nottingham University Hospitals NHS Trust. His clinical and research interests are in hypertension. Mark leads the hypertension service in Nottingham and leads an MRC funded research group focused on the molecular pathophysiology of sodium reabsorption in the distal nephron in Thiazide Induced Hyponatraemia and Gordon syndrome.
Mark is a member of the Prescribing Safety Assessment Board for UK medical students, and a member of the NICE hypertension in adults guideline committee.
Mr Richard Hoddes
Senior Interventional Radiographer, Manchester Royal Infirmary
Richard originally studied Physics, before completing a foundation degree in Allied Health Sciences and a BSc in Diagnostic Radiography (Salford). He is currently an Advanced Practitioner in interventional radiography at Manchester Royal Infirmary and Royal Manchester Children's Hospital.
Areas of interest include vascular access and promoting Radiographic role development. Post-graduate qualifications include Forensic Studies (Ulster) and Advanced Medical Imaging (Bradford). Richard has provided imaging for the Manchester University bioarchaeology group’s Egyptology studies.
Dr Mona Johnson
Senior Clinical Lead, NHS Digital
Dr Sanjay Kinra
Reader in Clinical Epidemiology and Honorary Consultant in Paediatrics, London School of Hygiene & Tropical Medicine
Dr Nicholas Latimer
Reader in Health Technology Assessment, University of Sheffield
Mr Christopher O'Regan
Head of Health Technology and Outcomes Research, Merck Sharp & Dohme
Christopher qualified in nursing after a period in the Armed Forces and spent 25 years in Critical Care Nursing After taking an MSc in Evidence Based Health Care at Oxford he entered the pharmaceutical industry. He heads a group with whose primary responsibility is developing Technology Appraisal submissions for NICE, SMC and the AWMSG. He maintains a strong academic interest in the methodologies underpinning comparative effectiveness research.
Professor Stephen Palmer
Professor of Health Economics, Centre for Health Economics, University of York
Stephen has worked in applied economic evaluation for over 15 years and currently heads the programme of work within TEEHTA supporting the NICE Technology Appraisal process and is a lead member of the NICE Decision Support Unit. He has a specific interest in the use of decision analytic modelling and evidence synthesis for technology assessment.
Professor Allyson Pollock
Director, Institute of Health and Society, Newcastle University
Allyson trained in medicine and is a public health physician and academic scholar. She is Director of the Institute of Health and Society in the Faculty of Medical Sciences, Newcastle University.
She has previously worked at University College London, the University of Edinburgh, and Queen Mary University of London, and was Director of Research and development at University College London Hospitals NHS Foundation Trust from 1998 to 2005.
Allyson’s current research is into access to medicines and appropriate medicines use, and pharmaceutical regulation and regulatory science, and the epidemiology of child and sports injury. She is well known for her active commitment, spanning more than two decades, to promoting universal public health care in the UK, and her expertise on marketisation and other aspects of health service reform.
Dr Stephen Smith, BSc MPhil MB BChir PhD MRCP
MRC Post-doctoral Clinical Research Fellow, University of Cambridge
Stephen is a clinical academic working at the University of Cambridge and EMBL-European Bioinformatics Institute. His clinical training is as a clinical pharmacologist and dermatologist at Addenbrookes in Cambridge.
Following a BSc in virology and PhD in Immuno-genomics from Edinburgh, he completed his medical degree in Cambridge, early clinical training at Addenbrookes and then MPhil from the Cambridge department of Applied Mathematics and Theoretical Physics. He went on to pursue an academic clinical career focused on applying bioinformatics to cancer biology. He has an ongoing interest in the application of computational modeling and machine learning techniques to healthcare datasets including to health economics and health technology. He joined committee B in 2017.
Consultant Urologist, Cambridge University Hospitals NHS Foundation Trust
Bill is one of three urologists in a specialist multidisciplinary team based in Cambridge. He trained in surgery in general and then in urology, in the UK and in Switzerland, in particular in bladder cancer and in reconstructive urology.
He has been Clinical Lead for Urology at Addenbrooke’s, Training Programme Director for Urology for East Anglia, and a member of the Cambridge Research Ethics Committee. He is currently the East of England Regional Representative on the Council of the British Association of Urological Surgeons.
He has previously been a member of Technology Appraisal Committees C and A, a member of the NICE Male Lower Urinary Tract Symptoms Guideline Development Group, clinical lead for the NICE Guideline Development Group on the Diagnosis and Treatment of Bladder Cancer, a member of the European Association for Urology Guideline Development Group on Incontinence and a member of the International Consultation on Urological Diseases consultations on BPH and on Bladder Cancer.
Professor Nicky J Welton BSc MSc PhD
Professor of Statistical and Health Economic Modelling, University of Bristol
Nicky graduated with a BSc in mathematics from Sheffield University, an MSc in statistics from University College London, and a PhD in mathematical biology from the University of Bristol. She is currently Professor of Statistical and Health Economic Modelling in the department of population health sciences at the University of Bristol. Here she leads the Multi-Parameter Evidence Synthesis research group, is Director of the departments Short Course Program, and Deputy Director of the Clinical Guidelines Technical Support Unit.
Her research interests include: methods for evidence synthesis in health technology assessment, network meta-analysis, extrapolating survival curves, bias adjustment in evidence synthesis, use of evidence in economic models, and value of information analysis.
Mr Nigel Westwood
Nigel left school and joined the Royal Navy as an officer in 1975. After initial training he served on a number of ships including appointments as a bridge watch-keeping officer, gunnery officer, navigating officer, specialist warfare officer, second-in-command and as captain. On moving ashore he joined the staff of the Commander-in-Chief Fleet with responsibility for controlling naval operations around the world before moving to a new NATO headquarters where he worked on NATO policy and negotiating allocation of forces with nations.
After completing the prestigious Joint Service Defence College course he took up an appointment in the Ministry of Defence in London working on future equipment requirements.
In 1997 he showed the first signs of what subsequently proved to be Ulcerative Colitis and despite an intensive drug regime, his condition deteriorated forcing him to undergo a pan-proctocolectomy and obliging him to leave the Royal Navy in the rank of commander after 25 years service. He now owns and runs an information technology business.
He has been an active volunteer with a number of charities and organisations particularly Crohn's and Colitis UK since his diagnosis serving as a trustee and vice-chairman for a number of years before stepping back for personal reasons in 2010.
Professor Sarah Wild
Professor of Epidemiology, University of Edinburgh
Dr Stuart Williams
Consultant Radiologist, Norfolk and Norwich University Hospital
Stuart qualified in medicine from Oxford University and worked in a variety of medical jobs in Oxford, Birmingham and London before returning to Oxford to train in radiology. Since 2001 he has been a consultant radiologist at Norwich and honorary senior lecturer at Norwich Medical School. He has variously been head of training, radiology clinical director, RCR regional chair and Trust lead for audit and improvement.
Between 2010 and 2013, Stuart was one of the first cohort of NICE clinical fellows and was subsequently a member of the guideline development group around recognition and referral of suspected cancer (NG12).